Black Licorice Compound Shows Promise Against Inflammatory Bowel Disease

Researchers from the University of Tokyo have developed a novel stem cell-based model of the human intestine to accelerate the discovery of treatments for inflammatory bowel disease (IBD). This breakthrough addresses the challenge of finding laboratory models that accurately mimic human intestinal conditions. Using this model, the team conducted high-throughput screening of approximately 3,500 compounds. They identified glycyrrhizin, a natural substance found in black licorice, as a highly effective anti-inflammatory candidate. The study, published in Stem Cell Reports, demonstrated that glycyrrhizin significantly reduced intestinal cell death and inflammation in both lab-grown tissues and mouse models. With IBD affecting millions globally and current therapies often providing insufficient relief, these findings offer a promising new avenue for drug development. However, researchers emphasize that further clinical studies are necessary to confirm the safety and efficacy of glycyrrhizin for human patients. This research highlights the potential of stem cell-derived models in transforming pharmaceutical discovery for chronic digestive conditions.